Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from

William B Kannel1, Philip A Wolf

  • 1Framingham Heart Study, 73 Mt. Wayte Avenue, Framingham, MA 01702-5827, USA. wkannel@bu.edu

Insights

Identifying major risk factors like dyslipidemia and hypertension is key to preventing atherosclerosis. Global risk assessment helps estimate the likelihood of peripheral artery disease and stroke, guiding necessary interventions.

Area of Science:

  • Cardiovascular Medicine
  • Public Health

Background:

  • Atherosclerosis is a major cause of cardiovascular disease, influenced by multiple risk factors.
  • Established risk factors such as dyslipidemia, hypertension, and smoking significantly contribute to atherosclerosis development.
  • These factors often cluster, necessitating comprehensive risk assessment.

Purpose of the Study:

  • To highlight the importance of major cardiovascular risk factors in atherosclerosis.
  • To emphasize the utility of multivariable risk profiles for peripheral artery disease and stroke.
  • To advocate for improved detection, evaluation, and control of these risk factors.

Main Methods:

  • Utilizing established risk factors (dyslipidemia, hypertension, glucose intolerance, adiposity, smoking, etc.) and markers of vascular damage (left ventricular hypertrophy, atrial fibrillation).
  • Formulating multivariable risk profiles for peripheral artery disease and stroke.
  • Reviewing the impact of standard cardiovascular risk factors on population-level cardiovascular disease.

Main Results:

  • Standard cardiovascular risk factors account for up to 85% of population-level cardiovascular disease.
  • Multivariable risk profiles aid in estimating the risk of disabling diseases like peripheral artery disease and stroke.
  • Risk factor clustering necessitates global risk assessment for effective management.

Conclusions:

  • Major cardiovascular risk factors are critical targets for prevention strategies.
  • Global risk assessment is essential for identifying individuals at high risk for atherosclerosis-related diseases.
  • Enhanced implementation of prevention guidelines is crucial, especially for high-risk populations.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...